MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 12 filers reported holding MONOPAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rappaport Reiches Capital Management, LLC | 10,695 | $14,867 | 0.01% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 23,455 | $32,605 | 0.00% |
| Tower Research Capital LLC (TRC) | 713 | $1 | 0.00% |
| JPMORGAN CHASE & CO | 2,414 | $3,000 | 0.00% |
| ROYAL BANK OF CANADA | 5,000 | $7,000 | 0.00% |
| VANGUARD GROUP INC | 99,976 | $138,977 | 0.00% |
| UBS Group AG | 6,388 | $8,879 | 0.00% |
| WELLS FARGO & COMPANY/MN | 31 | $43 | 0.00% |
| NORTHERN TRUST CORP | 37,051 | $51,505 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 41,892 | $59,486 | 0.00% |
| MORGAN STANLEY | 4,000 | $5,560 | 0.00% |
External links
This page lists MONOPAR THERAPEUTICS INC's shareholders in Q1 2023. To view MONOPAR THERAPEUTICS INC's shareholder history, click here.